Clincosm LogoSign in Get a demo

COVID-19

Showing NaN - NaN of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Worldwide (Baricitinib, Dexamethasone, Placebo)

Completed
Has Results
  • COVID-19
  • Birmingham, Alabama
  • +71 more
Jun 22, 2022

COVID-19 Trial in Phoenix, Baltimore, New York (Clazakizumab 25 mg, Clazakizumab 12.5 mg, Placebo)

Completed
Has Results
  • COVID-19
  • Clazakizumab 25 mg
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jun 10, 2022

Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)

Recruiting
  • Lower Respiratory Tract Infection
  • +3 more
  • Duarte, California
  • +59 more
Jun 3, 2022

COVID-19 Trial in Washington, Baltimore (Belnacasan, Placebo)

Recruiting
  • COVID-19
  • Washington, District of Columbia
  • +1 more
May 12, 2022

Prophylaxis and Treatment of COVID-19

Recruiting
  • COVID-19
  • Acute Respiratory Infection
    • Baltimore, Maryland
    • +1 more
    Apr 6, 2022

    COVID-19, Acute Kidney Injury, Chronic Kidney Injury Trial in United States

    Recruiting
    • COVID-19
    • +2 more
      • New Haven, Connecticut
      • +4 more
      Apr 13, 2022

      COVID-19 Trial in Worldwide (Placebo, Remdesivir)

      Completed
      Has Results
      • COVID-19
      • Birmingham, Alabama
      • +59 more
      Mar 9, 2022

      COVID-19 Trial in Worldwide (Interferon beta-1a, Placebo, Remdesivir)

      Completed
      Has Results
      • COVID-19
      • Interferon beta-1a
      • +2 more
      • Birmingham, Alabama
      • +63 more
      Mar 9, 2022

      COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

      Completed
      Has Results
      • COVID-19
      • Placebo
      • +2 more
      • Birmingham, Alabama
      • +70 more
      Mar 9, 2022

      BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)

      Withdrawn
      • COVID-19
        • Baltimore, Maryland
        • +2 more
        Feb 23, 2022

        Depression, Anxiety, Inflammation, COVID-19 Trial in Baltimore (Placebo, 300mg MYMD-1, 600mg MYMD-1)

        Not yet recruiting
        • Depression, Anxiety
        • +2 more
        • Placebo
        • +2 more
        • Baltimore, Maryland
          Johns Hopkins Bayview Medical Center
        Feb 7, 2022

        COVID-19, ARDS, Human, Stem Cells Trial in Baltimore (MRG-001, Placebo)

        Recruiting
        • COVID-19
        • +3 more
        • Baltimore, Maryland
          Johns Hopkins Medicine
        Jan 30, 2022

        COVID-19, Lung Inflammation Trial in Baltimore (Regadenoson, Placebo Control)

        Recruiting
        • COVID-19
        • Lung Inflammation
        • Baltimore, Maryland
          University of Maryland Medical Center
        Jan 21, 2022

        The Impact of COVID-19 on Maternal and Neonatal Outcomes

        Recruiting
        • COVID-19
        • Pregnancy; Infection
        • mRNA COVID-19 vaccine (Pfizer or Moderna)
        • Baltimore, Maryland
          Johns Hopkins Hospital
        Jan 14, 2022

        COVID-19 Trial in Russian Federation, United States (Placebo, Ruxolitinib)

        Terminated
        Has Results
        • COVID-19
        • Scottsdale, Arizona
        • +35 more
        Jan 14, 2022

        COVID-19 Positive Patients Using the DANA App

        Completed
        • COVID-19
        • DANA app
        • Baltimore, Maryland
          Johns Hopkins Psychiatry department
        Jan 7, 2022

        COVID-19 Vaccine Response in Sickle Cell Disease

        Recruiting
        • Sickle Cell Disease
        • COVID-19
        • COVID-19 Vaccine
        • Washington, District of Columbia
        • +5 more
        Dec 2, 2021

        COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,

        Completed
        Has Results
        • COVID-19
        • +3 more
        • Hydroxychloroquine Sulfate
        • Ascorbic Acid
        • Los Angeles, California
        • +7 more
        Dec 14, 2021

        COVID-19 Trial in Worldwide (RDV, Placebo to Match RDV)

        Terminated
        Has Results
        • COVID-19
        • RDV
        • Placebo to Match RDV
        • Chandler, Arizona
        • +103 more
        Nov 4, 2021

        COVID-19 Trial in Baltimore (Crizanlizumab, 0.9% saline)

        Completed
        Has Results
        • COVID-19
        • Baltimore, Maryland
          Johns Hopkins Hospital
        Nov 3, 2021

        Covid-19, Sars-CoV2 Trial in Los Angeles, Baltimore (Multiple Doses of Anti-SARS-CoV-2 convalescent plasma)

        Terminated
        • Covid-19
        • Sars-CoV2
        • Multiple Doses of Anti-SARS-CoV-2 convalescent plasma
        • Los Angeles, California
        • +1 more
        Nov 1, 2021

        COVID-19 Trial in Hialeah, Baltimore, Houston (APX-115, Placebo)

        Recruiting
        • COVID-19
        • Hialeah, Florida
        • +2 more
        Oct 24, 2021

        COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)

        Completed
        Has Results
        • COVID-19
        • Aurora, Colorado
        • +33 more
        Oct 8, 2021

        Covid-19 Trial in United States (HCQ, HCQ+AZT, Placebo)

        Completed
        Has Results
        • Covid-19
        • Fullerton, California
        • +6 more
        Oct 7, 2021

        SARS-CoV-2/COVID-19 Prevalence Study

        Completed
        • COVID-19
          • Aurora, Colorado
          • +14 more
          Sep 29, 2021